成人免费看AA片,18以下勿进色禁网站永久,2020亚洲А∨天堂在线直播

EN| News Releases
News Releases

News Releases

Home>News Releases
CR Pharmaceutical proposed to acquire 10.0% stake in Immunotech Biopharm

Press time:2021-07-20From:CR Pharma [Font:BigMediumSmall]

On 20 July, Beijing Pharmaceutical Investment and Management (BVI) Limited, a wholly-owned subsidiary of the Company and as a purchaser (Purchaser), and Yue Cheng International Capital (HK) Limited, Hualida Development Co. Limited, Ren Xiaojuan and Bei Ni Ltd as sellers (collectively, the Sellers), amongst others, entered into a share purchase agreement (the Share Purchase Agreement), pursuant to which the Purchaser conditionally agreed to purchase, and the Sellers conditionally agreed to sell, an aggregate of 51,458,400 ordinary shares of Immunotech Biopharm Ltd (Immunotech) (representing 10.0% of the total issued share capital of Immunotech as of the date of this announcement) at a total consideration of approximately HK$ 799.66 million, representing a price of HK$ 15.54 per share (the Proposed Acquisition). 

Immunotech together with its subsidiaries (Immunotech Group; Stock Code: 6978.HK) is a cellular immunotherapy biopharmaceutical company in China focusing on the research, development and commercialization of T cell immunotherapy. Immunotech Group has been deeply involved in the field of cellular immunotherapy for around 15 years, has established an experienced research and development team and full-scale technology platform, and has obtained the relevant intellectual property rights for its core technology and products. 

The Proposed Acquisition marks an important step for CR Pharmaceuticals to enter the field of cellular immunotherapy, reflecting the Companys recognition of Immunotech Groups value in the field of T cell immunotherapy and its optimism about the market of this field. Cellular immunotherapy is an important development direction for tumor therapy in the future. Through the Proposed Acquisition, it is expected that the Group can complete its strategic layout in the field of cellular immunotherapy. 

 
 
Back to Top

  • <menuitem id="bgbmp"><rp id="bgbmp"><em id="bgbmp"></em></rp></menuitem>

    <form id="bgbmp"></form>
  • <strong id="bgbmp"><strong id="bgbmp"><object id="bgbmp"></object></strong></strong>

    主站蜘蛛池模板: 紫金县| 墨玉县| 安多县| 桐柏县| 左权县| 社旗县| 固安县| 尼勒克县| 资溪县| 宁强县| 静海县| 资溪县| 南通市| 磴口县| 响水县| 苏尼特右旗| 白水县| 佛坪县| 弥勒县| 莒南县| 张北县| 合江县| 余姚市| 永川市| 阳泉市| 怀集县| 富蕴县| 晴隆县| 朔州市| 乐亭县| 东台市| 凤台县| 汝州市| 睢宁县| 安泽县| 建水县| 淄博市| 南充市| 左权县| 衡阳县| 双鸭山市|